Literature DB >> 10234980

Long-term outcome of surgical treatment of intracavernous giant aneurysms.

I Date1, T Ohmoto.   

Abstract

A number of approaches have been proposed for the treatment of intracavernous giant aneurysms. In the present study, we have analyzed long-term surgical outcome of 27 consecutive cases of our experience. All the cases were unruptured and symptomatic, showing symptoms such as extraocular movement disorder or visual disturbances. Thirteen cases were male and 14 cases were female. The age of the patients ranged between 11 and 75 years (average 52.2 years) and follow-up periods were between 1 and 20 years (average 7.7 years). Abducens nerve was distributed in 20 cases, oculomotor nerve in 12 cases, optic nerve in six cases, trigeminal nerve in six cases, and trochlear nerve in five cases. In addition to conventional angiography, three-dimensional computed tomographic angiography, balloon test occlusion (BTO), slow injection angiography, aneurysmography, and single photon emission computed tomography with BTO were used to determine a method of treatment. Therapeutic modalities of the present series were as follows: four cases were unoperated, common carotid artery ligation was performed in eight cases, internal carotid artery (IC) ligation in three cases, IC ligation plus superficial temporal artery (STA)--middle cerebral artery (MCA) anastomosis in four cases, IC ligation plus high flow vein bypass in three cases, IC trapping plus STA-MCA anastomosis in three cases, and direct clipping in two cases. Although two cases showed early and late ischemic complications, other cases demonstrated improvement of cranial nerve dysfunction relatively soon after surgical treatment and long-term outcome was generally good. It is concluded that good long-term surgical outcome is obtained for intracavernous giant aneurysms by selecting adequate surgical treatment based upon careful preoperative evaluation of these aneurysms using sophisticated diagnostic methods.

Entities:  

Mesh:

Year:  1998        PMID: 10234980     DOI: 10.2176/nmc.38.suppl_62

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  7 in total

1.  A giant thrombosed aneurysm of the petrous carotid artery presenting with cavernous sinus syndrome: case report.

Authors:  I Date; K Sugiu; T Ohmoto
Journal:  Skull Base Surg       Date:  1999

2.  Clinical and angiographic outcome of endovascular and conservative treatment for giant cavernous carotid artery aneurysms.

Authors:  Zhenhai Zhang; Xianli Lv; Zhongxue Wu; Youxiang Li; Xinjian Yang; Chuhan Jiang; Ruxiang Xu; Chunsen Shen
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

3.  EC-IC bypass for cavernous carotid aneurysms: An initial experience with twelve patients.

Authors:  G Menon; Sudhir Jayanand; K Krishnakumar; S Nair
Journal:  Asian J Neurosurg       Date:  2014-04

4.  Intraoperative Computed Tomography (CT) for Treating Giant Carotid Intracavernous Aneurysms.

Authors:  Zhe Xue; Fuyu Wang; Zhenghui Sun; Hui Zhang; Chen Wu; Dongsheng Kong; Bainan Xu
Journal:  Med Sci Monit       Date:  2017-06-22

5.  Does Universal Bypass before Carotid Artery Occlusion Obviate the Need for Balloon Test Occlusion: Personal Experience with Extracranial-Intracranial Bypass in 23 Patients.

Authors:  Girish Menon; Sudha Menon; Ajay Hegde
Journal:  J Neurosci Rural Pract       Date:  2019 Apr-Jun

6.  The outcome of a surgical protocol based on ischemia overprotection in large and giant aneurysms of the anterior cerebral circulation.

Authors:  Hideaki Imai; Katsushige Watanabe; Takaaki Miyagishima; Yuhei Yoshimoto; Taichi Kin; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Neurosurg Rev       Date:  2016-05-06       Impact factor: 3.042

7.  Management of Cavernous Carotid Artery Aneurysms: A Retrospective Single-Center Experience.

Authors:  Michael Karl Fehrenbach; Eric Dietel; Tim Wende; Johannes Kasper; Caroline Sander; Florian Wilhelmy; Ulf Quaeschling; Juergen Meixensberger; Ulf Nestler
Journal:  Brain Sci       Date:  2022-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.